Haedal Protocol vs Injective — how do they compare? Haedal Protocol trades at Rp297.84 (market cap Rp141,54M, Rp30,88M 24h volume), while Injective trades at Rp76,507 (market cap Rp7,62T, Rp1,05T 24h volume). The key difference: Injective is far larger — about 53836.4× Haedal Protocol's market cap, and Haedal Protocol's supply is capped (483,3M / 1B HAEDAL (49%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Haedal Protocol for 15 Days and Injective for 37 Days on average.
| HAEDAL | INJ | |
|---|---|---|
Market Cap | Rp141,54M | Rp7,62T |
Volume (24h) | Rp30,88M | Rp1,05T |
Circulating Supply | 483,3M / 1B HAEDAL (49%) | 100M INJ |
Typical Hold Time | 15 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Haedal Protocol currently trades at Rp288.18 with a market cap of Rp139.43M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 49% circulating supply with an average hold time of 15 days. Current price sits near the pivot point of Rp288, with immediate support at Rp283 and resistance at Rp292. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity and limited market depth. Investors should monitor for any protocol developments that could drive adoption.
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.
Read more on HAEDAL →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →